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Abstract
Efficient infection control requires potent T-cell responses at sites of pathogen replication. However, the regulation of T-cell
effector function in situ remains poorly understood. Here, we show key differences in the regulation of effector activity
between CD4+ and CD8+ T-cells during skin infection with HSV-1. IFN-c-producing CD4+ T cells disseminated widely
throughout the skin and draining lymph nodes (LN), clearly exceeding the epithelial distribution of infectious virus. By
contrast, IFN-c-producing CD8+ T cells were only found within the infected epidermal layer of the skin and associated hair
follicles. Mechanistically, while various subsets of lymphoid- and skin-derived dendritic cells (DC) elicited IFN-c production
by CD4+ T cells, CD8+ T cells responded exclusively to infected epidermal cells directly presenting viral antigen. Notably,
uninfected cross-presenting DCs from both skin and LNs failed to trigger IFN-c production by CD8+ T-cells. Thus, we
describe a previously unappreciated complexity in the regulation of CD4+ and CD8+ T-cell effector activity that is subset-
specific, microanatomically distinct and involves largely non-overlapping types of antigen-presenting cells (APC).
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Introduction
Infection results in the priming of pathogen-specific T-cell
responses in LNs draining the site of infection. Depending on the
nature of the pathogen, this critical step in generating adaptive
immunity involves the interaction of naive T cells with various
types of migrating and LN-resident DCs [1,2]. During skin
infection with herpes simplex virus (HSV)-1, LN-resident CD8a+
DCs and skin-derived CD103+ DCs can activate naı¨ve CD8+ T-
cells, presumably through the cross-presentation pathway involv-
ing the acquisition of noninfectious antigen [1–4]. By contrast, all
subsets of skin-derived migratory DCs, including epidermal
Langerhans cells, dermal CD11b+ and dermal CD103+ DCs, in
addition to LN-resident CD8a+ DCs acquire the ability to
stimulate naive HSV-specific CD4+ T cells [1,2,4]. Following
appropriate activation by DCs, T cells undergo a program of
clonal expansion, which is accompanied by the acquisition of
effector functions and the induction of migration molecules that
facilitate their infiltration of infected tissues.
While CD4+ helper T cells support the generation of antibody
and CD8+ T-cell responses in lymphoid tissues, both CD4+ and
CD8+ T-cells also contribute directly to pathogen control at sites of
infection [5,6]. The latter is achieved through two principle
effector functions: the contact-dependent elimination of infected
tissue cells and the local production of inflammatory and
antimicrobial cytokines [5,6]. The extent to which these T-cell
activities contribute to immunity depends on the nature of the
infection. For instance, control of non-cytopathic viruses, such as
lymphocytic choriomeningitis virus, strictly requires cytolytic T-
cell activity [7]. By contrast, immunity against cytolytic viruses,
such as vaccinia and vesicular stomatitis virus, does not rely on
target cell elimination by T cells [8]. Instead, under circumstances
where infection will ultimately result in lytic cell death regardless of
T-cell killing, pathogen containment and clearance is dependent
on the production of cytokines by effector CD4+ and CD8+ T cells
[9–11]. Together these diverse effector T-cell (TEFF) activities are
essential for efficient immune protection, however, they may also
cause the destruction of uninfected tissues, as seen in the context of
immunopathology, autoimmunity or transplant rejection. There-
fore, a detailed understanding of T-cell-mediated immunity in
peripheral tissues forms an essential basis for therapeutic
interventions to modulate T-cell responses against both harmful
and innocuous antigens. Nevertheless, the cellular and molecular
mechanisms controlling T-cell effector activities in nonlymphoid
organs remain poorly defined [2,10].
At its simplest, T-cell effector functions are regulated by T-cell
receptor (TCR) stimulation through peptide-MHC complexes on
APCs. Importantly in this respect, disengagement of the TCR
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from antigen-MHC complexes results in the immediate cessation
of T-cell cytokine production [10,12]. This ‘‘on-off cycling’’ of
effector activity provides a sophisticated level of antigen specificity
and places important temporal and spatial constraints on TEFF-cell
responses [10]. As a consequence, effector T cells circulating
through the blood or uninfected tissues are thought to shutdown
cytokine production and to regain this effector function only upon
reencounter with antigen in infected tissues [10]. In addition,
noncognate signals delivered through inflammatory mediators and
costimulatory molecules, such as interleukin (IL)-18, IL-12, type I
IFNs or CD80 and CD86, may also trigger or further modulate T-
cell cytokine production and cytotoxic activity [13–16]. Thus, the
presence of appropriate APCs providing antigen stimulation
together with accessory signals is critical in regulating T-cell
immunity in situ and targeting effector activities to pathogen-
containing tissues [2,17]. Indeed, various types of professional and
nonprofessional APCs, including monocyte-derived inflammatory
DCs, B cells, neutrophils and parenchymal cells, have been
suggested to elicit T-cell effector functions within nonlymphoid
tissues [15,18–21]. Key aspects in this regulation, however,
particularly those pertaining to the infection status of APCs and
the role of distinct APC subtypes in driving CD4+ versus CD8+
TEFF-cell responses, remain poorly understood.
Here, we define the cellular interactions that control TEFF-cell
activity during the course of skin infection with HSV-1. We focus
our analysis on the production of IFN-c, a central component of
adaptive immune responses. IFN-cexerts proinflammatory and
regulatory effects on a variety of target cells, including the
stimulation of antimicrobial activity and the induction of MHC
molecules and inflammatory chemokines [5,6]. Protection from
HSV infection strictly requires TEFF-cell activities, with both CD4
+
and CD8+ T cells contributing to virus control in skin, mucosa and
sensory ganglia [22–26]. Moreover, efficient immunity against
HSV infection requires IFN-c [27] and, interestingly, it has been
proposed that production of this cytokine rather than cytolytic
activity is the major CD8+ T-cell mechanism for virus control in
neuronal tissues [28,29] as well as during lytic infection in genital
mucosa [26]. The shared role of IFN-c as a key effector molecule
produced by both CD4+ and CD8+ T cells allowed us to directly
compare the regulation of these TEFF-cell subsets side by side. We
further took advantage of the tropism of HSV-1 for epithelial
tissues [30] to document a distinct anatomical distribution of IFN-
producing TEFF-cell subsets in relation to the presence or absence
of infectious virus in different microanatomical compartments.
Importantly, this unexpected spatial segregation of TEFF-cell
effector activity was a direct result of the involvement of largely
non-overlapping subsets of professional and nonprofessional APCs
in driving CD4+ and CD8+ TEFF-cell responses.
Results
Distribution of IFN-c-producing TEFF cells
To determine population kinetics and cytokine production by
TEFF cells in lymphoid and peripheral tissues, we utilized a skin
infection with HSV-1 in combination with adoptive transfer of
TCR-transgenic T cells specific for determinants derived from the
HSV glycoproteins gB (CD8+ gBT-I cells) [31] and gD (CD4+
gDT-II cells) [4], respectively. Consistent with the tropism of HSV
for epithelial tissues, immunofluorescence microscopy (IFM) of
skin revealed that infection was largely confined to the epidermal
layer and hair follicle epithelium (Fig. S1A). Separation of
epidermal and dermal tissue (Fig. S1B,C) revealed that HSV-
specific TEFF cells began to infiltrate infected skin around 5 days
post-infection, albeit with fewer cells in the smaller epidermal
compartment (Fig. 1A). TEFF-cell numbers peaked around 8 days
after inoculation and declined thereafter (Fig. 1A).
To analyze the production of IFN-c by TEFF cells in situ, we
adopted protocols that facilitate intracellular cytokine staining
following exposure to the Golgi inhibitor brefeldin A (BFA), either
in vivo after intravenous injection [15,32] and/or ex vivo
immediately after tissue harvest and during enzymatic digestion
[21]. Of note, in order to focus our analysis on IFN-c production
in situ, neither of these approaches involved overt restimulation
with high concentrations of peptide antigen ex vivo. A consider-
able portion of gBT-I and gDT-II TEFF cells in the epidermis and
dermis of infected skin produced IFN-c 5–6 days post-infection
(Fig. 1B–D). Concomitant with clearance of infectious virus from
skin [25], IFN-c production by TEFF cells ceased around day 7,
with virtually no IFN-c+ TEFF cells present 8 days post-infection
(Fig. 1D). Similar kinetics of IFN-c production were also observed
for endogenous CD8+ and CD4+ TEFF cells (Fig. S2A,B). While
roughly equal portions of gDT-II cells produced IFN-c in the
epidermal and dermal layers of skin 5 days after infection, the
fraction of IFN-c+ gBT-I cells was approximately 3-fold higher in
the epidermis as compared to the dermis (Fig. 1C,D). Note, that
dermal preparations contained hair follicles of epithelial origin and
therefore also harbored some replicating virus (Fig. S1A–C). The
broader distribution of IFN-c+ gDT-II cells in the skin also
extended to lymphoid tissues, with skin-draining axillary and
brachial LNs, but not spleen, containing an appreciable fraction of
IFN-c-producing gDT-II cells (Fig. 1E,F). By contrast, IFN-c+
gBT-I cells were virtually absent from all lymphoid tissues.
Together, these results suggested a distinct anatomical distribution
of IFN-c-producing CD4+ and CD8+ TEFF cells in both peripheral
and lymphoid tissues.
Confinement of IFN-c+ CD8+ TEFF cells to skin epithelium
To gain further insight into the microanatomical localization of
IFN-c-producing TEFF-cell subsets, we obtained skin tissue for
IFM analysis. Staining of skin sections with anti-IFN-c antibodies
Author Summary
HSV-1 is a widely distributed pathogen causing a life-long
latent infection associated with periodic bouts of reacti-
vation and severe clinical complications. Adaptive immune
responses encompassing CD4+ and CD8+ T-cell activities
are key to both the clearance of infectious virus and the
control of latent infection. However, precisely how such T-
cell responses are regulated, particularly within acutely
infected peripheral tissues, remains poorly understood.
Using a mouse model of HSV-1 skin infection, we describe
a complex regulation of T-cell responses at the site of
acute infection. These responses were subset-specific and
anatomically distinct, with CD4+ and CD8+ T-cell activities
being directed to distinct anatomical compartments within
the skin. While IFN-c-producing CD4+ T cells were broadly
distributed, including skin regions a considerable distance
away from infected cells, CD8+ T-cell activity was strictly
confined to directly infected epithelial compartments. This
unexpected spatial segregation was a direct consequence
of the involvement of largely non-overlapping types of
antigen-presenting cells in driving CD4+ and CD8+ T-cell
effector activity. Our results provide novel insights into the
cellular regulation of T-cell immunity within peripheral
tissues and have the potential to guide the development
of T-cell subset-specific approaches for therapeutic and
prophylactic intervention in antimicrobial immunity and
autoimmunity.
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confirmed the presence of IFN-c-producing cells during the acute
phase of infection (Fig. 2A,B), with both endogenous CD4+ and
CD8+ (Fig. S2C,D), as well as transgenic gBT-I and gDT-II TEFF
cells (Fig. 2C,D) contributing to this response. Interestingly,
although gBT-I TEFF cells were broadly distributed throughout the
skin, IFN-c+ gBT-I cells were strictly confined to the epidermis
and hair follicle epithelium (Fig. 2C). By contrast, the majority of
IFN-c+ gDT-II cells localized to the dermal layer, where they were
found either in association with hair follicles or in considerable
distance to the epithelium (Fig. 2D). Thus, in contrast to the strict
confinement of IFN-c+ CD8+ TEFF cells to the epithelium, the
dermal layer was the predominant site of the CD4+ T-cell IFN-c
response.
Antigen requirements for IFN-c production by TEFF cells
The kinetics of IFN-c production by TEFF cells suggested that
the presence of infectious virus was likely to play a role in the
induction of cytokine production. This was indeed the case, as
gBT-I and gDT-II TEFF cells primed by HSV infection did not
produce IFN-c in non-specifically inflamed skin after treatment
with 1-fluoro-2,4-dinitrobenzene (DNFB) (Figs. 3A and S3A).
Likewise, in vitro activated gBT-I TEFF cells transferred into
HSV-infected mice lacking H-2Kb molecules (H-2Kb2/2) did not
produce significant amounts of IFN-c in the skin (Figs. 3B,C
and S3B). Transfer of activated TEFF cells was necessary as H-
2Kb2/2 mice cannot prime naı¨ve gBT-I cells due to lack of the
relevant MHC-I restriction element. IFN-c production by
transferred gBT-I TEFF cells was completely restored in similar
experiments following HSV-1 infection of bone marrow chimeric
mice in which H-2Kb molecules were expressed exclusively in
radioresistant cells, but were absent from the radiosensitive
hematopoietic compartment (Figs. 3D and S3C). By contrast,
we observed a significant reduction in the frequency of in vivo
primed IFN-c+ gBT-I cells in chimeric mice in which H-2Kb
molecules were selectively missing from radioresistant cells, when
compared with fully MHC-I-sufficient control chimeras (Figs. 3E
and S3D). Interestingly, the overall frequencies of IFN-c+ gBT-I
TEFF cells appeared to be increased in this particular experimental
set-up, possibly related to altered immune activation thresholds in
previously irradiated recipient mice. Regardless, these results
indicated that presentation of viral antigens by radioresistant
epithelial cells, such as keratinocytes, Langerhans cells [33] and
dendritic epidermal T cells (DETC) [34], was necessary and
sufficient for optimal IFN-c responses by gBT-I TEFF cells.
Figure 1. Distribution of IFN-c+ TEFF cells. Mice received naı¨ve gBT-I or gDT-II cells prior to HSV-1 skin infection. (A) Quantification of TEFF cells in
epidermis (Epi) and dermis (Der) 5–10 days post-infection, tracked as CD45.2+CD45.1+ Va2+ (gBT-I) or Va3.2+ (gDT-II) cells (dispase digestion). Data
pooled from n= 9–14 mice/time point. (B,C) Analysis of IFN-c+ TEFF cells in skin (dispase digestion) 5 days post-infection. **, P,0.01; ns, not significant
by Mann Whitney test; n=5–6 mice/group from 3–4 experiments. (D) Analysis of IFN-c+ TEFF cells 5–10 days post-infection; n= 4–7 mice/time point
from 1–4 experiments. (E,F) Analysis of IFN-c+ TEFF cells in skin (gBT-I, epidermis; gDT-II, total skin), brachial (brLN) and axillary (axLN) LNs and spleen
(5 days post-infection in E, or as indicated in F); n= 2–7 mice/organ/time point from 1–4 experiments.
doi:10.1371/journal.ppat.1004303.g001
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IFN-c production by gDT-II cells was also a consequence of
antigen recognition, as in vitro activated gDT-II TEFF cells
transferred into infected MHC-II-deficient mice (I-A/E2/2) failed
to produce IFN-c (Figs. 3F,G and S3E). Transfer of activated
gDT-II cells was necessary to overcome the inability of I-A/E2/2
mice to support CD4+ T-cell priming. By contrast, gDT-II TEFF
cells primed in vivo produced IFN-c in chimeric mice in which
only radiosensitive, but not radioresistant cells expressed MHC-II
molecules, although we observed a moderate, yet significant
reduction in the frequency of IFN-c+ gDT-II cells in this situation
(Figs. 3H and S3F). These results implied that bone marrow-
derived MHC-II+ APCs were largely responsible for presentation
of viral antigens and eliciting cytokine production by CD4+ TEFF
cells.
DCs trigger IFN-c production by CD4+ TEFF cells
Consistent with an involvement of MHC-II-expressing APCs in
driving CD4+ TEFF-cell responses, MHC-II
hi cells accumulated in
the skin during the first week post-infection [35] (Fig. S4A,B). The
majority of these cells had a CD11cintCD11b+ phenotype and
further expressed CD64 and MAR-1, identifying them as
monocyte-derived inflammatory DCs [36,37] (Fig. S4C). IFM
of infected skin revealed a broad distribution of MHC-II+ cells,
with the vast majority localizing to the dermal layer, where they
were found in close proximity to IFN-c+ gDT-II cells (Fig. 4A).
Indeed, partial depletion of CD11c+ DCs upon diphtheria toxin
(DT) treatment of CD11c.DTR mice resulted in a significant
reduction in the frequency of IFN-c+ gDT-II cells in infected skin
(Figs. 4B,C and S5A). Furthermore, treatment of mice with
Figure 2. Localization of IFN-c+ TEFF cells in infected skin. IFM analysis of skin, 5 (A,D), 6 (C) and 8 (B) days post-infection, stained with anti-
keratin and -IFN-c antibodies, as indicated. (C,D) Detection of HSV-specific TEFF cells after transfer of GFP
+ naı¨ve gBT-I (C) and gDT-II (D) cells prior to
infection. Scale bars: A-i, 100 mm; A-ii, 2 mm; B, 200 mm; C-i, 70 mm; C-ii, 10 mm; C-iii, 10 mm; D-i, 200 mm; D-ii, 10 mm; D-iii, 10 mm. Photos
representative of n= 4–6 mice/group.
doi:10.1371/journal.ppat.1004303.g002
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antibodies blocking the costimulatory molecules CD80 and CD86,
typically expressed by professional APCs such as DCs, also
abrogated the CD4+ TEFF-cell IFN-c in skin and draining LNs
(Figs. 4D and S5B). In stark contrast, costimulation blockade
had no bearing on IFN-c production by gBT-I TEFF cells
(Fig. 4D). These experiments suggested that MHC-II+ DCs were
the main drivers of cytokine production by CD4+ TEFF cells.
Nevertheless, in Ccr22/2 mice, an absence of monocyte-derived
DCs [20,38], which numerically dominated the cutaneous DC
network during acute infection, rather increased than decreased
Figure 3. MHC-dependent activation of TEFF cells by APCs. (A) Mice received naı¨ve gBT-I or gDT-II cells prior to HSV-1 skin infection and DNFB
treatment on opposite flanks. Analysis of IFN-c+ gBT-I and gDT-II cells from skin (collagenase digestion) 5 days post-infection. Data representative of
n= 2 experiments with skin pooled from 4 mice each. (B–D) Wild-type (WT) and H-2Kb2/2 mice or WTRWT and H-2Kb2/2RWT bone marrow
chimeric mice were subjected to HSV-1 skin infection and transferred with in vitro activated gBT-I cells 3 days post-infection. (E) WTRWT and WTRH-
2Kb2/2 mice received naı¨ve gBT-I cells prior to infection. (B–E) Analysis of IFN-c+ gBT-I cells from axillary LN (B) and epidermis (Epi, dispase digestion,
C–E) 5 days post-infection. **, P,0.01; ***, P,0.001; ns, not significant by Mann Whitney test; n= 7–14 mice/group from 3–5 experiments. (F,G) WT
and I-A/E2/2 mice were subjected to HSV-1 skin infection and transferred with in vitro activated gDT-II cells 3 days later. Analysis of IFN-c+ gDT-II cells
from skin (collagenase digestion) and axillary LNs 5 days post-infection. *, P,0.05; **, P,0.01 by Mann Whitney test; 3 experiments with n= 2–4 mice/
group; symbols for skin represent values from pooled tissues. (H) WTRWT and WTRI-A/E2/2 mice received naı¨ve gDT-II cells prior to infection.
Analysis of IFN-c+ gDT-II cells in skin (collagenase digestion) and axillary LNs 5 days post-infection. *, P,0.05 by Mann Whitney test; n= 9–19 mice/
group from 3 experiments.
doi:10.1371/journal.ppat.1004303.g003
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the frequency of IFN-c+ gDT-II and gBT-I cells (Fig. S5C,D),
potentially related to impaired virus control in these mice [20].
Furthermore, we observed normal IFN-c production by gDT-II
and gBT-I TEFF cells in the absence of Langerhans cells, CD103
+
dermal DC and CD8+ LN-resident DCs upon DT treatment of
Langerin.DTR mice [39,40], and similarly, also in B-cell-deficient
mMT mice [41] (Fig. S5E–G). These results suggested a level of
redundancy regarding the involvement of different types of
professional APCs in regulating CD4+ TEFF activities in infected
skin.
Multiple DC subsets activate CD4+ TEFF cells
To more directly establish a role for DCs in CD4+ T-cell
responses, we utilized an ex vivo stimulation assay in which APCs
purified from infected mice were cocultured with in vitro
generated TEFF cells. Initial experiments revealed that maximal
IFN-c production occurred 18 hours after antigen-dependent
restimulation for gDT-II and 5 hours for gBT-I TEFF cells (Fig.
S6A,B). We purified CD11chi DCs from HSV-infected skin and
divided them into CD11bhi and CD11blo subsets (Fig. 5A), with
the former expected to contain monocyte-derived and dermal DCs
and the latter expected to contain Langerhans cells and CD103+
dermal DCs [4,37,40]. Notably, both subsets induced robust IFN-
c production by gDT-II TEFF cells, whereas monocytes
(CD11b+CD11c2Ly6Chi) and neutrophils (CD11b+CD11c2Ly6-
Cint) failed to do so (Fig. 5B,C). Unexpectedly, none of these
APCs induced IFN-c production by gBT-I TEFF cells (Fig. 5B,C).
This was not related to potentially compromised expression of H-
2Kb molecules after APC isolation, since all subtypes triggered
IFN-c production by gBT-I TEFF cells when pulsed with high
doses of gB-peptide prior to cell sorting (Fig. S6C,D). In separate
experiments, we specifically sorted CD103+ dermal DCs, as this
DC subset is capable of cross-presenting viral antigens to CD8+ T
cells during skin infection [4]. Once again, while both CD103+
and CD1032 CD11chi DCs triggered IFN-c production by gDT-
II TEFF cells, neither of the two subsets activated gBT-I TEFF cells
(Fig. 5D). Remarkably, this disparate response also extended to
DCs isolated from LNs draining the site of infection with CD103+,
CD11b+, CD8a+ and Langerhans cell-containing
CD1032CD11b2CD8a2 subsets inducing IFN-c production by
gDT-II, but not gBT-I TEFF cells (Fig. 5E). Of note, gBT-I TEFF
cell unresponsiveness towards DC stimulation was observed
irrespective of the culture period for 5–18 hours (not shown).
Together, these results demonstrated that various skin-derived and
LN-resident DC subsets acquired and presented viral antigen for
the activation of CD4+ TEFF cells. By contrast, none of these DCs
elicited IFN-c-production by CD8+ TEFF cells, even though at
least some of them, namely the CD8a+ and CD103+ subsets, have
the ability to present viral antigens for the activation of naı¨ve
CD8+ T cells [3,4].
Epithelial APCs activate CD8+ TEFF cells
Given that IFN-c+ gBT-I cells were found exclusively in skin
epithelium (Figs. 1B–D and 2B), we reasoned that this compart-
ment contained APCs capable of stimulating CD8+ TEFF cells.
Therefore, we purified CD45.2+ hematopoetic and CD45.22
parenchymal and stromal cells from epidermal sheets of infected
mice by cell sorting and tested their ability to activate CD8+ TEFF
cells. Note that here we used expression of CD45.2 to distinguish
between hematopoeitc and non-hematopoeitc epidermal cells,
whereas in other analyses we used this molecule as a marker for
CD45.1+CD45.2+ gBT-I and gDT-II cells. Both fractions induced
IFN-c production by gBT-I TEFF cells, although the keratinocyte-
containing CD45.22 subset appeared to be slightly more potent in
this regard (Fig. 6A,B). Induction of IFN-c production was
antigen-specific, since co-cultured OT-I TEFF cells of an irrelevant
specificity did not respond to either of the APC subsets (Fig.
S7A,B). Furthermore, stimulation of IFN-c production by
CD45.22 epidermal APCs was specific for CD8+ TEFF cells since
these APCs failed to activate gDT-II TEFF cells (Figs. 6B and
S7C). In line with this, the vast majority of CD45.22 epidermal
cells from infected skin lacked expression of MHC-II molecules
(Fig. S7D). To better define the nature of epidermal APCs
capable of stimulating CD8+ TEFF cells, we sorted these cells into
keratinocytes (CD45.22EpCAM+), DCs (CD45.2+CD11chi),
DETCs (CD45.2+Vc3+), as well as residual CD45.2+CD11c2
cells. As expected, keratinocytes induced moderate levels of IFN-c
production by gBT-I TEFF cells, and so did epidermal DCs
(Fig. 6C,D), in contrast to their counterparts isolated from total
skin preparations and LNs (Fig. 5C–E). While residual CD45.2+
epithelial cells had only a weak stimulatory capacity, remarkably,
DETCs were by far the most potent APCs triggering IFN-c
production by gBT-I TEFF cells (Fig. 6C,D).
Only infected APCs activate CD8+ TEFF cells
Given that the epidermis was the predominant site of viral
replication in vivo, we hypothesized that the stimulatory capacity
of epidermal APCs resulted from their direct infection. In
agreement, intravital two-photon microscopy of skin infected with
a cyan fluorescent protein (CFP)-expressing HSV-1 strain revealed
that slow-moving gBT-I TEFF cells were swarming around virally
infected epidermal cells (Movie S1). By contrast, gBT-I TEFF cells
more distal to infection foci displayed significantly higher mean
velocities (Fig. 7A,B). Importantly, using IFM, we observed that
IFN-c+ gBT-I cells co-localized with HSV-infected cells in the
epidermis and hair follicle epithelium (Fig. 7C). To further
identify infected cells, we inoculated mice with a recombinant
strain of HSV-1 expressing green fluorescent protein (HSV.GFP)
and analyzed epidermal cells 5 days post-infection using flow
cytometry. We observed small numbers of GFP-expressing cells
amongst various populations of epidermal cells, including kerati-
nocytes (CD45.22EpCAM+), DETCs (CD45.2+Vc3+), Langer-
hans cells (CD45.2+EpCAM+MHC-IIhi), other DCs (CD45.2+Ep-
CAM2MHC-IIhi), as well as undefined CD45.2+MHC-II2 cells
(Fig. 7D). As expected, GFP+ cells were absent after infection with
the wild-type HSV-1 KOS strain. Next, we sorted GFP+ and
GFP2 DETCs, MHC-IIhi DCs and keratinocytes from epidermal
sheets (Fig. 7E) and tested their ability to stimulate TEFF cells ex
vivo. Strikingly, all GFP+, presumably infected, APCs were able to
trigger IFN-c production by gBT-I TEFF cells (Fig. 7F,H). In
contrast, IFN-c production was not elicited by their GFP2
counterparts. Finally, DCs, but not DETCs, elicited IFN-c
production by gDT-II TEFF cells, irrespective of their GFP-
expression status (Fig. 7G,H). Together, these results indicated
that various types of epidermal APCs induced cytokine production
by CD8+ TEFF cells. Importantly, direct viral infection was a strict
requirement for their stimulatory capacity. Overall, our data
highlight a previously unappreciated complexity in the regulation
of T-cell effector activity that was subset-specific, microanatomi-
cally distinct and involved largely non-overlapping subsets of
professional and nonprofessional APCs for CD4+ and CD8+ T-cell
responses (Fig. S8).
Discussion
Our results highlight a stringent and complex regulation of
TEFF-cell responses that targets effector activities strictly to the site
of infection and related lymphoid tissues. Thus, IFN-c production
Regulation of T-Cell Effector Activity
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was limited to the time of acute infection and occurred in an
antigen-dependent fashion, requiring in situ restimulation via
peptide-MHC complexes on bone marrow-derived professional
APCs for CD4+ TEFF cells and on directly infected tissue cells for
CD8+ TEFF cells. Consistent with a critical involvement of DCs in
peripheral CD4+ TEFF-cell responses, we observed a pronounced
accumulation of monocyte-derived inflammatory DCs in infected
skin. Such DCs are thought to exert multiple functions, including
the local production of inflammatory mediators [42], trafficking of
antigen to lymph nodes [43] and replenishment of peripheral DC
populations following the resolution of infection [35,44]. In
addition, our experiments employing genetic approaches, ex vivo
stimulation assays and costimulation blockade provide compelling
evidence that DCs in inflamed skin play a key role in stimulating
CD4+ T-cell effector activity. These results reinforce the concept
that DCs regulate various aspects of peripheral T-cell responses
[2,15,20,21,45,46]. In fact, the presence of DCs appeared to be
essential for CD4+ TEFF-cell responses as non-professional APCs,
such as keratinocytes and DETCs, largely lacked MHC-II
expression and failed to elicit IFN-c production in ex vivo assays.
It is possible that certain APC subsets may dominate the regulation
of peripheral CD4+ TEFF-cell activities, as suggested for
CD11chiCD11bhi dermal DCs after skin injection of model
antigens [21] or CCR2-depedent monocyte-derived inflammatory
DCs during mucosal HSV-2 infection [20]. Nevertheless, our
study revealed a considerable degree of redundancy in this regard,
with various DC populations from skin and LNs displaying strong
stimulatory capacities for CD4+ TEFF cells. These results imply
that all DC subsets, relative to their abundance in infected skin,
contribute to CD4+ TEFF activation in vivo. Consistent with this,
we observed normal IFN-c+ production in mice deficient in
specific APC subsets, such as monocyte-derived DCs, Langerhans
cells, CD103+ dermal DCs or B cells. According to our analysis,
monocyte-derived inflammatory DCs are by far the most
abundant DC subtype in HSV-infected skin [35] and therefore,
may be the major drivers of peripheral CD4+ TEFF-cell responses
during HSV-1 skin infection. Nevertheless, our results demon-
strate that they may not be essential in this regard as other DC
subsets may compensate for their absence.
The IFN-c response by CD4+ T cells occurred in both draining
LNs and the epithelial and dermal layers of infected skin, including
regions a considerable distance away from infection foci in the
epithelium. This remarkably broad distribution echoes the diverse
functions of CD4+ TEFF cells in infection control, ranging from the
initiation of antibody class-switching in LNs to the regulation of
inflammatory cell infiltration and activity as well as direct
antimicrobial effects within infected tissues [5]. Interestingly in
this respect, IFN-c can exert long-range effects on target cells
located as far as 80 mm from CD4+ TEFF-cell-APC conjugates, as
recently shown for skin infection with Leishmania major [47].
Thus, DC-mediated CD4+ TEFF-cell activation in the dermis may
be an essential component of the host defense that restricts
infection to the skin epithelium and limits its spread after virus
reemergence in sensory nerve endings. The importance of the
CD4+ TEFF-cell response is further illustrated by the lack of CD8
+
TEFF-cell IFN-c production in the dermis, as shown here.
Supporting this notion, CD4+ TEFF-cell responses are thought to
dominate the clearance of HSV-1 from the skin [22,23], most
Figure 4. CD11c+ DCs drive IFN-c production by CD4+ TEFF cells in vivo. (A) Mice received GFP
+ gDT-II cells prior to HSV-1 skin infection. IFM
analysis of skin 5 days post-infection after staining with anti-MHC-II and -IFN-c antibodies. Arrows indicate IFN-c+ gDT-II cells. Scale bars: A-i, 100 mm;
A-ii, 20 mm; A-iii, 20 mm. (B,C) CD11c.DTR mice received naı¨ve gDT-II cells prior to HSV-1 skin infection and 4 days post-infection were treated with
diphtheria toxin (DT) or PBS (Ctrl). Analysis of IFN-c+ gDT-II cells in skin (collagenase digestion). ***, P,0.001 by Mann Whitney test; n=11–15 mice/
group from 3 experiments. (D) Wild-type mice received naı¨ve gDT-II or gBT-II cells prior to infection and 4 days post-infection were treated with anti-
CD80/86 (aCD80/86) or isotype control (Isotype) antibodies. Analysis of IFN-c+ gDT-II cells in skin (collagenase digestion) and axillary LNs, and of IFN-
c+ gBT-I cells in epidermal sheets (dispase digestion) days 5 post-infection. *, P,0.05; **, P,0.01; ns, not significant by Mann Whitney test; n=6–7
mice/group from 2–3 experiments.
doi:10.1371/journal.ppat.1004303.g004
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likely via antibody-independent functions such as direct inflam-
matory and antiviral activities [5,48,49].
In striking contrast to the stimulation requirements for CD4+
TEFF cells, we identified nonprofessional APCs, such as keratino-
cytes and DETCs, as the main drivers of IFN-c production by
CD8+ TEFF cells. According to our histological analysis, keratino-
cytes are the most abundant cell type in infected epidermis
suggesting that they may be largely responsible for activating
CD8+ TEFF cells. In addition, various types of inflammatory cells
that infiltrate the epithelial layer during infection may contribute
to this response. Importantly, both keratinocytes and DETCs are
highly susceptible to direct infection by HSV-1 in vivo [30,50].
Indeed, their stimulatory capacity, and surprisingly also that of
epidermal DCs, was strictly dependent on direct infection. DETCs
are invariant cd-T cells that form a dense network in the epidermis
of mice and have been implicated in both innate and adaptive
immune responses [51]. Interestingly, it has been speculated that
human cd-T cells may act as professional APCs capable of
stimulating naı¨ve CD4+ T cells [52], although we did not find
evidence supporting a similar role for DETCs, as they failed to
Figure 5. Multiple DC subsets elicit IFN-c production by CD4+ but not CD8+ TEFF cells. (A) Sorting strategy used to isolate CD11c
+CD11blo
and CD11c+CD11bhi DCs, CD11c2Ly6Cint neutrophils (Neut) and CD11c2Ly6Chi monocytes (Mono) from skin 5 days after HSV-1 infection. (B,C)
Analysis of IFN-c+ cells after culture of in vitro activated gDT-II and gBT-II effector cells with 56104 (B) or increasing numbers (C) of sorted APCs
pooled from 10–20 mice. Culture period, 5 h for gBT-I and 18 h for gDT-II cells. Data pooled from 2–3 experiments. (D,E) Analysis of IFN-c+ TEFF cells
cultured with indicated DC subsets pooled from 10–20 mice and sorted from skin (D; 1.56104) or axillary LNs (E; 56104) 5 days after infection as in
B,C. LC, Langerhans cells. Representative plots from 2–3 independent experiments.
doi:10.1371/journal.ppat.1004303.g005
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activate CD4+ TEFF cells. Nevertheless, their contribution to CD8
+
T-cell responses may be particularly relevant at lesion borders
where high numbers of infected DETCs [50] could elicit strong
IFN-c responses required to curb the lateral spread of infection. In
addition to DETCs, other epidermal-infiltrating T cells may also
act as potent APCs for local CD8+ TEFF cells upon infection with
virus [53]. A role for infected T cells and DCs in triggering local
CD8+ TEFF-cell activity is further supported by our observation
that chimeric mice, in which only radiosensitive APCs could
activate CD8+ T cells, had a residual IFN-c response.
Despite the fact that all DC subsets could activate CD4+ TEFF-
cells, only HSV-infected epidermal DCs were capable of activating
CD8+ TEFF cell to produce IFN-c. Strikingly, uninfected DCs
from the same location failed to stimulate CD8+ TEFF cells,
highlighting the importance of direct infection in determining the
outcome of CD8+ TEFF-cell-DC interactions. Previous studies have
suggested that various types of professional and nonprofessional
APCs, including inflammatory DCs and neutrophils, can trigger
IFN-c production by CD8+ TEFF cells during pulmonary infection
with influenza virus [15,18]. Given the ability of influenza virus to
infect a broad range of target cells in addition to its primary
tropism for lung epithelial cells [17], it is tempting to speculate that
in this situation, direct infection may also be required for CD8+ T-
cell activation. Supporting this notion, a large number of
inflammatory DCs and neutrophils from influenza virus-infected
lungs express viral antigens, most likely as a consequence of direct
infection [15,18], and infected neutrophils display a far superior
ability to elicit CD8+ TEFF-cell cytokine production than their
uninfected counterparts [18].
One of the more surprising findings from our study was that
uninfected DCs failed to elicit IFN-c production by CD8+ TEFF
cells, even though they had access to viral antigen and efficiently
activated CD4+ TEFF cells. We have previously shown that LN
DCs are able to activate naı¨ve CD8+ T cells at various stages
during skin infection, unequivocally demonstrating that they
present viral antigens in the context of MHC-I molecules
[3,4,54]. The CD8a+ and CD103+ DC subsets are of particular
interest in this regard, because those DCs cross-present viral
antigens in draining LNs 5 days after HSV-1 infection [4],
corresponding to the time point analyzed here. Despite this,
CD103+ DCs from skin and LNs failed to trigger IFN-c
production by CD8+ TEFF cells. This finding parallels observations
with CD8+ T-cell responses to migratory DCs after influenza virus
infection, where naı¨ve but not memory T cells proliferate in
response to antigen presented on migratory DCs [55].
Although not directly addressed in our study, it is tempting to
speculate that the inability of uninfected DCs to activate CD8+
TEFF cells may be a means to prevent their elimination by
triggering cytotoxic effector functions. While T-cell killing of DCs
has been proposed to represent a negative feedback regulation on
T-cell priming [56,57], it should be noted that prolonged antigen
presentation is a common feature in a variety of infections [58–
61]. Therefore, CD8+ T-cell-mediated elimination of DCs in vivo
may be inefficient at best, which is also consistent with our
preliminary data demonstrating the failure of gBT-I TEFF cells to
lyse CD103+ DCs from LN of HSV infected mice during short-
term co-culture. The DC-dependent production of IFN-c by
CD4+ TEFF cells observed in our study further supports this
assumption. Of note in this respect, minute amounts of surface
antigen can trigger T-cell cytotoxicity [62,63]. Furthermore, cross-
presenting nonprofessional APC, such as liver sinusoidal endothe-
lial cells, can drive CD8+ T-cell TNFa production during viral
hepatitis [64]. Thus, it appears unlikely that quantitative
differences in antigen presentation between directly infected and
cross-presenting DCs alone can explain the CD8+ TEFF-cell
unresponsiveness described here. In the light of this, and given that
Figure 6. Epidermal APCs trigger IFN-c production by CD8+ TEFF cells. (A,B) Analysis of IFN-c
+ in vitro activated gBT-I (A,B) and gDT-II (B) TEFF
cells cultured (as in Figure 5) with increasing numbers of CD45.22 and CD45.2+ APCs sorted from epidermal sheets (pooled from 20 mice) 4 days
after HSV-1 skin infection. Data representative (A) or pooled from 2–3 experiments (B). (C,D) Analysis of IFN-c+ in vitro activated gBT-I cells cultured
with sorted APCs from epidermal sheets (pooled from 20 mice) 4 days after infection. APC numbers were 56104 for keratinocytes (KC), CD11c+ and
residual CD45.2+CD11c2Vc32 (CD45.2+) cells; 36104 for DETCs. Data representative (C) or pooled from 2 experiments (D). **, P,0.01 by student t-
test individually comparing specific APC subsets to control conditions (No APC).
doi:10.1371/journal.ppat.1004303.g006
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Figure 7. Only directly infected APCs activate CD8+ TEFF cells. (A,B) Mice were subjected to skin infection with HSV.CFP and 3 days later
received in vitro activated GFP+ gBT-I effector cells. Intravital two-photon microscopy of infected skin 5 days post-infection. (A) Maximum intensity
projection image corresponding to Movie S1. Yellow circle indicates area with slow moving gBT-I cells. 2HG, second harmonic generation signal;
scale bar, 50 mm. (B) Mean velocities of gBT-I cells in contact with (Proximal) or distal to (Distal) virus-infected cells from one movie, representative of
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infected epidermal DCs were indeed able to trigger CD8+ TEFF-
cell IFN-c production, we speculate that direct infection may alter
the functional status of DCs, for instance through interference with
putative inhibitory pathways [65], to allow for the activation of
CD8+ TEFF cells. Such modulation of DC stimulation thresholds
may be particularly relevant when low levels of peptide-MHC-I
complexes are presented to CD8+ TEFF cells. Further studies will
be required to elucidate the precise molecular mechanisms
operating in DCs and/or T cells to prevent the activation of
CD8+ TEFF cells by uninfected cross-presenting DCs.
Overall, the stringent temporal, cellular and molecular
constraints on TEFF-cell responses identified in our study are
likely in place to prevent collateral damage and autoimmune
inflammation initiated by TEFF-cell activation in tissues not
involved in infection. Our results are compatible with a scenario
where CD8+ T-cell responses are strictly focused on infected tissue
compartments, whereas CD4+ responses may induce a more
regional state of antimicrobial protection in tissues surrounding
infection foci. Having identified dramatically distinct requirements
for CD4+ and CD8+ T-cell effector activity, our study has
provided novel insights into the regulation of cellular immune
responses in nonlymphoid tissues. Such knowledge has the
potential to guide the development of T-cell subset-specific
approaches for therapeutic and prophylactic intervention in
antimicrobial immunity and autoimmunity.
Materials and Methods
Ethics statement
All experiments were done according to Australian NHMRC
guidelines contained within the Australian Code of Practice for the
Care and Use of Animals for Scientific Purposes and under
approvals ID1112038 and ID1112345 from the University of
Melbourne Animal Ethics Committee.
Mice
C57BL/6, B6.SJL-PtprcaPep3b/BoyJ (B6.CD45.1), gBT6
B6.CD45.1 (gBT-I.CD45.1), gBT-I.EGFP, gBT-I.DsRed, OT-
I6B6.CD45.1 (OT-I.CD45.1), gDT-II6B6.CD45.1 (gDT-
II.CD45.1), gDT-II.EGFP, C57BL/6Ji-Kbtm1N12 (H-2Kb2/2),
B6.129S2-H2dlAb1-Ea/J (MHC-II2/2), CD11c.DTR, B6129.CCR2
(Ccr22/2), Langerin.DTR.EGFP (Lg.DTR.EGFP) and mMT mice
were bred in the Department of Microbiology and Immunology.
gBT-I.CD45.1 and gDT-II.CD45.1 are F1 generation offspring
expressing both CD45.1 and CD45.2.
Viruses
HSV-1 KOS, KOS pCMV/EGFP Cre (HSV.GFP) and 17
HSVgDUL47DYFP (HSV.CFP) were grown and titrated as
previously described [46]. HSV.GFP expresses an EGFP/Cre
fusion gene under the control of the CMV-IE promoter from the
intergenic space between UL3 and UL4 resulting in EGFP
expression by infected cells. HSV.CFP was derived from HSV-1
gDUL47 (strain 17 expressing YFP from UL47 and CFP-tagged
gD protein) [66], from which the YFP was removed and sequences
from UL47 restored. HSV.GFP and HSV.CFP were made by
homologous recombination between parent viral genomes with
appropriate transfer plasmids in 293A cells after which green/
yellow fluorescence were selected for and against, respectively.
Final recombinants were verified by PCR and sequencing of
relevant parts of the genome after at least three rounds of plaque
purification.
Bone marrow chimeric mice
Mice were irradiated with two of doses 550 cGy 3 hours apart
followed by reconstitution with 56106 T-cell-depleted donor bone
marrow cells and treatment with purified anti-Thy1 antibody
(clone T24/31.7 from hybridoma supernatants) 1 day later.
Chimeric mice were allowed to reconstitute for at least 8 weeks
before experiments. WTRI-A/E2/2 chimeras were not treated
with anti-Thy1 antibody and received 56106 enriched splenic
CD4+ T cells from wild-type mice 1 day and 4 weeks after
irradiation.
Viral infections and DNFB, diphtheria toxin and antibody
treatments
Mice were infected on their flanks with 16106 plaque-forming
units of HSV-1, as previously described [25]. For DNFB
treatment, 15 mL of 0.5% (w/v) DNFB was applied to flank skin,
as previously described [67]. For depletion of CD11c+ cells,
CD11c.DTR mice were injected with 200 ng diphtheria toxin
(DT) or PBS intraperitoneally and intradermally 4 d post-
infection. Langerin.DTR mice were injected with 500 ng DT or
PBS control intraperitoneally. For costimulation blockade, mice
were injected with 0.25 mg anti-CD80 (16-10A1) and -CD86
(GL1) blocking antibodies or rat IgG2 (B81-3) and IgG2a (R35-95)
control antibodies (BD Pharmingen) intraperitoneally 4 d post-
infection.
Adoptive transfer of transgenic T cells
gBT-I and gDT-II cells were isolated from lymphoid tissues and
gDT-II cells were further enriched by positive and negative
selection using magnetic beads, as described previously [4]. 56104
gBT-I or 16104 gDT-II cells were transferred into naı¨ve mice
intravenously via the tail vein, respectively. For transfer of in vitro
activated T cells, 1.56106 transgenic cells were injected.
In vitro activation of transgenic T cells
Splenic gBT-I or OT-I cells were activated with peptide-pulsed
splenocytes, as previously described [25]. Purified gDT-II cells
were activated by co-culture for 5 days with 46107 irradiated wild-
type splenocytes pulsed with 10 mM of gD315–327 in the presence of
2 mg LPS (Sigma). Cells were cultured in 20 ml RPMI 1640
(Department of Microbiology and Immunology) supplemented
with 10% FCS (CSL), 5 mM HEPES (Gibco), 2 mM glutamine
(Gibco), 561025 M 2-b-mercaptoethanol (Sigma), antibiotics
(Gibco, CSL) (RP-10) and 4 mg lipopolysaccharide. On days
8 movies from 4 individual mice. (C) Mice received naı¨ve GFP+ gBT-I cells prior to HSV-1 skin infection. IFM analysis of skin stained with anti-HSV-1 and
-IFN-c antibodies. Yellow arrow indicates IFN-c+, red arrows IFN-c2 gBT-I cells. Scale bar, 50 mm. Insert (C-ii) from indicated area in C-i, without green
and red channels. Photos representative of n=10 sections from 2 individual mice. (D–H) Mice were subjected to skin infection with HSV.WT or
HSV.GFP. (D) Analysis of GFP+ keratinocytes (KC, CD45.22EpCAM+), MHC-IIhi cells (CD45.2+MHChiEpCAM2), DETCs (CD45.2+Vc3+), Langerhans cells (LC,
CD45.2+MHC-IIhiEpCAM+) and residual CD45.2+ cells (MHC-II2Vc32) from epidermal sheets 5 days post-infection. Plots representative of n=5 mice.
(E) Sorting strategy used to purify epidermal GFP+ (HSV) and GFP2 (Ctrl) DETCs, MHC-IIhi cells and keratinocytes (pooled from 20 mice) 4 days post-
infection. (F–H) Analysis of IFN-c+ in vitro activated TEFF cells cultured (as in Figure 5) with GFP
+ or GFP2 MHC-IIhi cells (8–136104), DETCs (7–
106104) and keratinocytes (14–166104) from epidermal sheets (pooled from 20 mice) 4 days after infection. Data representative (F,G) or pooled from
2–4 experiments (H).
doi:10.1371/journal.ppat.1004303.g007
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2–4, respectively, all cultures were diluted 1:2 in fresh medium
containing 20 U/mL recombinant human IL-2 (PeproTech).
Isolation of skin cells and ex vivo analysis of IFN-c
production
As indicated, skin tissue was chopped and digested with 3 mg/
ml collagenase type 3 (Worthington Biochemicals, USA) and 5 mg
DNase (Roche, Germany) for 90 min at 37uC. Alternatively, skin
was digested in 2.5 mg/mL dispase II (Roche) diluted in PBS for
90 min at 37uC. Then, the epidermis and dermis were separated
mechanically and epidermal sheets were incubated in trypsin/
EDTA (0.25%/0.1%) (SAFC Biosciences), while the dermis was
chopped and incubated in collagenase type 3 and DNase, as
previously described [49]. When analyzing ex vivo IFN-c
production, 10 mg/mL Brefeldin A (Sigma) was included during
each enzymatic digestion step. For some experiments, mice were
additionally injected with 0.25 mg BFA intravenously 6 hours
prior to sacrifice.
Enrichment of DCs
Axillary lymph nodes of HSV-1-infected mice were desiccated
with a scalpel blade and digested with continual mixing in RPMI
1640 containing 1 mg/mL collagenase type 3 and 2 mg/mL
DNase for 20 min, prior to the addition of 600 mL 0.1 M EDTA
and continual mixing for 5 minutes further. DCs were subse-
quently enriched for by magnetic beads, as previously described
[4].
In vitro cultures of T cells and APCs
APC subsets were stained with the appropriate monoclonal
antibodies, purified by cell sorting using a FACSAria III (BD
Pharmingen) and then washed and resuspended in RP-10.
Increasing concentrations of the APCs were cultured with
1.256104 in vitro activated transgenic T cells in round bottom
plates for 5 to 18 hours, as indicated, in the presence of 10 mg/mL
BFA for the last 5 hours.
Flow cytometry and antibodies
Antibodies were from BD Pharmingen: anti-CD3 (145-2C11), -
CD4 (RM4-5), -CD8a (53-6.7), -CD11b (M1/70), -CD19 (ID3), -
CD45.1 (A20), -CD80 (16-10A1), -CD86 (GL1), -IFN-c
(XMG1.2), -Ly6C (AL21), -NK1.1 (PK136), -Va2 (B20.1) and -
Vb8 (MR5-2); from eBioscience: anti-CD45.2 (104) and -CD11c
(N418); or from BioLegend: anti-CD326 (g8.8) and -Va3.2 (RR2-
16). For intracellular staining, cells were fixed with a Cytofix/
Cytoperm kit (BD Pharmingen). A FACSCanto II (BD Pharmin-
gen) and FlowJo software (TreeStar) were used for analysis.
Propidium iodide (Sigma Aldrich) and SPHERO calibration
particles (BD Pharmingen) were added for identification of live
cells and enumeration.
Immunofluorescence and confocal microscopy
Skin was fixed at room temperature for 30 min in PLP buffer
(0.2 M NaH2PO4, 0.2 M Na2HPO4, 0.2 M L-lysine and 0.1 M
sodium periodate with 2% paraformaldehyde), washed twice with
PBS and incubated for 30 min in 20% sucrose, prior to being
embedded, frozen, cut and stained as previously described [48].
IFN-c staining (AlexaFluor647, BD Pharmingen) was performed
overnight at 4uC (1:75 in PBS containing 2.5% [w/v] donkey
serum). Anti-keratin-5 and -14 polyclonal antibodies were from
Jomar Biosciences; anti-CD4 (RM4-5) from BioLegend; anti-CD8
(53.67) from BD Pharmingen and polyclonal anti-HSV from Dako
North America. Slides were mounted with ProLongGold antifade
media (Invitrogen), air-dried and viewed using a Zeiss LSM700
confocal microscope and Imaris 7.1 software (Bitplane).
Intravital two-photon microscopy
Mice were anesthetized and HSV-1-infected flank skin was
mounted on an imaging platform and acquired with an upright
LSM710 NLO multiphoton microscope as described previously
[48]. Imaging data was processed and automatic cell tracking
aided by manual corrections was performed with Imaris 7.1
software. For movies, image sequences were composed in Adobe
After Effects CS5.
Statistical analysis
Graphs were plotted using Prism 5 (Graphpad) and comparison
of data sets was performed by one-way analysis of variance
followed by Tukey post-test, or Mann-Whitney or student t tests,
as indicated. All graphs depict means 6 s.e.m..
Supporting Information
Figure S1 Topography of HSV-1 skin infection and
preparation of epidermal sheets. (A) IFM analysis of skin
stained with anti-HSV antibody 5 days after infection. Arrows indicate
HSV-infected epithelial cells in the epidermis (Epi) and hair follicles
(HF). Scale bars: A-i, 100 mm; A-ii, 50 mm. (B) Schematic diagram
and (C) IFM analysis depicting the enzymatic and mechanical
separation of epidermis and dermis. Note that the dermis preparation
contains hair follicles (HF) of epithelial origin. Epithelial cells depicted
by staining with anti-keratin antibody. Scale bar, 200 mm.
(TIF)
Figure S2 Distribution of endogenous IFN-c+ TEFF cells
in infected skin. (A,B) Mice were subjected to HSV-1 skin
infection. Analysis of IFN-c+ (A) CD8+ and (B) CD4+ T cells
(collagenase digestion) 5 and 8 days post-infection. (C,D) IFM
analysis of skin 5 days after infection stained with anti-HSV-1,
-IFN-c, -CD8 (C) or -CD4 (D) antibodies. Scale bars, C-i,
100 mm; C-ii, 20 mm; D-i, 100 mm, D-ii, 20 mm. Photos
representative of n.5 sections from 2 mice/group.
(TIF)
Figure S3 Experimental setups. (A) Experimental setup for
Figure 3A. Wild-type mice received naı¨ve gBT-I or gDT-II cells
and 1 day later were subjected to HSV-1 skin infection on their left
flank followed by skin treatment with DNFB on the right flank 2
days post-infection. Analysis of IFN-c+ gBT-I and gDT-II cells
from both flanks 5 days post-infection. (B,C) Experimental setup
for Figure 3B–3D. Wild-type (WT) and H-2Kb2/2 mice (B), or
WTRWT and H-2Kb2/2RWT bone marrow chimeric (C) were
subjected to HSV-1 skin infection and 3 days later received in vitro
activated gBT-I effector cells. Analysis of IFN-c+ gBT-I cells
isolated from epidermal sheets 5 days post-infection. (D)
Experimental setup for Figure 3E. WTRWT and WTRH-
2Kb2/2 mice received naı¨ve gBT-I cells and 1 day later were
subjected to infection. Analysis of IFN-c+ gBT-I cells from
epidermal sheets 5 days post-infection. (E) Experimental setup
for Figure 3F and 3G. Wild-type (WT) and I-A/E2/2 mice
were subjected to HSV-1 skin infection and 3 days later received
in vitro activated gDT-II cells. Analysis of IFN-c+ gDT-II cells
isolated from skin and axillary LNs 5 days post-infection. (F)
Experimental setup for Figure 3H. WTRWT and WTRI-A/
E2/2 mice received naı¨ve gDT-II cells and 1 day later were
subjected to infection. Analysis of IFN-c+ gDT-II cells from skin
and axillary LNs 5 days post-infection.
(TIF)
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Figure S4 Infiltration of HSV-infected skin by
CD11c+MHC-II+ APCs. (A–C) Mice were subjected to HSV-
1 skin infection. Analysis of APCs from skin (collagenase
digestion) at the indicated time points. (A) Plots gated on
PI2CD45.2+ cells. (B) Enumeration of CD11cint/+MHC-II+
DCs. (C) Analysis of CD11b, CD103, CD64 and MAR-1
expression on DC populations gated as indicated. Data from
n=4–5 mice/per group.
(TIF)
Figure S5 TEFF-cell activation in absence of specific APC
subtypes. (A) Depletion of DCs in DT-treated CD11c.DTR
mice. Representative plots, gated on CD45.2+PI2 cells, show the
proportion of CD11c+MHC-II+ DCs in spleen and skin of
CD11c.DTR mice treated with PBS or DT according to
Figures 4B and 4C. (B) Experimental setup for Figure 4D.
Wild-type mice received naı¨ve gBT-I or gDT-II cells prior to
HSV-1 skin infection and were treated with blocking anti-CD80
and -CD86 or isotype control antibodies 4 days post-infection.
Analysis of IFN-c+ gBT-I and gDT-II cells in epidermal sheets
(gBT-I, dispase digestion) or skin (gDT-II, collagenase digestion)
and axillary LNs 5 days post-infection. (C,D) Wild-type (WT) or
Ccr22/2 mice received naı¨ve gBT-I or gDT-II cells prior to HSV-
1 skin infection. (C) Representative plots show the proportion of
LyChiLy6G2 monocytes and of CD11c+MHC-IIhi APCs in the
skin of WT and Ccr22/2 mice 5 days post-infection. (D) Analysis
of IFN-c+ gBT-I (epidermis, dispase digestion) and gDT-II cells
(dermis, collagenase digestion). *, P,0.05; ns, not significant by
Mann Whitney test; n=4–5 mice/group from 1 experiment (for
gBT-I) and n=11–16 mice/group from 4 experiments (for gDT-
II). (E,F) Depletion of langerin+ cells in DT-treated Langerin.DTR
mice. Langerin.DTR mice were subjected to HSV-1 skin infection
and 4 days later treated with DT (500 ng) or PBS (Ctrl).
Representative plots depict the proportion of Langerhans cells
(MHC-IIhi EpCAM+) amongst PI2CD45.2+ cells in skin
(collagenase digestion). (F) Mice received naı¨ve gBT-I or
gDT-II cells prior to infection. gBT-I-recipient mice were
treated with DT (500 ng) or PBS (Ctrl) 4 days post-infection,
and gDT-II-recipient mice were treated 2 days prior and 2 and
4 days after infection. Analysis of IFN-c+ gBT-I cells in the
epidermis (dispase digestion) or gDT-II cells in the skin
(collagenase digestion). Ns, not significant by Mann Whitney
test; n= 10–14 mice/group from 2–4 experiments. (G) Wild-
type (WT) or mMT mice received naı¨ve gDT-II cells prior to
infection. Analysis of IFN-c+ gDT-II cells in skin (collagenase
digestion). Data from 2 experiments with skin tissue pooled
from 4 individual mice each.
(TIF)
Figure S6 TEFF-cell IFN-c production triggered by
peptide-pulsed APCs. (A,B) Analysis of IFN-c+ in vitro
activated gBT-I and gDT-II effector cells cultured for 5–18 hours
in the absence (Ctrl) or presence of gB498–505-peptide (gBT-I) or
16105 splenocytes and gD315–237-peptide (gDT-II). Representative
plots gated on gBT-I and gDT-I cells, as indicated. (C,D) Mice
were subjected to HSV-1 skin infection and 5 days post-infection
APCs were isolated from skin (collagenase digestion), pulsed with
0.1 mg/mL gB498–505 peptide for 1 hour, and then sorted into
CD11c+CD11blo and CD11c+CD11bhi DCs, CD11c2Ly6Cint
neutrophils (Neut) and CD11c2Ly6Chi monocytes (Mono), as
described in Figure 5A. (C,D) Analysis of IFN-c+ in vitro
activated gBT-I effector cells cultured for 5 hours in the presence
of the indicated APC subsets (56104 each in C, increasing
numbers as indicated in D). Data representative of (C) or pooled
from (D) 2 experiments.
(TIF)
Figure S7 Distinct epidermal APC subsets trigger IFN-c
production by CD4+ and CD8+ TEFF cells. (A,B) Analysis of
IFN-c+ in vitro activated gBT-I (Vb8+) and OT-I (Vb82) cells co-
cultured in the absence (A) or presence of increasing numbers of
CD45.22 or CD45.2+ cells (B) from epidermal sheets 4 days after
HSV-1 skin infection, as in Figure 6A. Data from one
experiment. (C) Analysis of IFN-c+ in vitro activated gDT-II
effector cells cultured in the presence of increasing numbers of
CD45.22 or CD45.2+MHC-IIhi cells from epidermal sheets 4 days
after infection. Data from 1 (CD45.2+MHC-IIhi APCs) or 2
(CD45.22 APCs) experiments. (D) Analysis of MHC-II expression
by CD45.2+ and CD45.22 cells isolated from epidermal sheets
(Epi) 5 days after infection.
(TIF)
Figure S8 Distinct regulation of IFN-c production by
CD4+ and CD8+ T cells during HSV-1 skin infection. (A)
Different distribution of IFN-c+ CD4+ and CD8+ TEFF cells during
HSV-1 skin infection. IFN-c+ CD4+ TEFF cells are broadly
distributed within infected skin and associated lymphoid tissues.
By contrast, IFN-c+ CD8+ TEFF cells are strictly confined to
epithelial skin regions harboring infectious virus, including the
epidermis and hair follicles, and are absent from lymphoid tissues.
(B) This distinct anatomical distribution of IFN-c+ CD4+ and
CD8+ TEFF cells results from their different responsiveness
towards stimulation by APCs. Irrespective of their infection
status, MHC-II+ professional APCs, such as DCs, activate CD4+
TEFF cells in skin epithelium, dermis and LNs, whereas
nonprofessional APCs, such as keratinocytes or DETCs, fail to
do so. By contrast, IFN-c production by CD8+ TEFF cells is
triggered only by directly infected cells, the majority of which are
nonprofessional epithelial APCs, such as keratinocytes and
DETCs. Noninfected DCs in the dermis or draining LNs fail to
elicit IFN-c production by CD8+ TEFF cells, even though they
activate CD4+ TEFF cells and initiate division and effector
differentiation of naı¨ve CD8+ T cells.
(TIF)
Movie S1 Reduced velocity of CD8+ TEFF cells in
proximity to HSV-infected cells. Wild-type mice were
subjected to skin infection with HSV.CFP and received in vitro
activated gBT-I cells 3 days post-infection. A representative
59 min time-lapse movie of infected skin taken 5 days post-
infection. The second harmonic generation signal (2HG) marks
the collagen-rich dermal layer. The time-lapse is shown at 8
frames per second. Movie is representative of 8 movies from n=4
mice from 2 experiments. Scale bar, 30 mm.
(MP4)
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